SCHEMBL17110206

SCHEMBL17110206

CCOC(=O)c1cnn([C@H]2CC[C@](C)(C(C)=O)CC2)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.40
ALDH1A1 P00352 6/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.37
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
PDE4B Q07343 1/20 0.36
PLAT P00750 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17099119 0.91 LMNA (0.40) LMNAALDH1A1NPC1RAB9ANPSR1
SCHEMBL17099121 0.91 LMNA (0.40) LMNAALDH1A1NPC1RAB9ANPSR1
SCHEMBL1407037 0.87 LMNA (0.47) LMNAALDH1A1NPC1RAB9ANPSR1
SCHEMBL17110207 0.86 LMNA (0.50) LMNAALDH1A1NPC1RAB9AHTT
SCHEMBL1407209 0.84 LMNA (0.48) LMNAALDH1A1NPC1RAB9ANPSR1
SCHEMBL1406792 0.84 LMNA (0.51) LMNAALDH1A1NPC1RAB9ANPSR1
SCHEMBL1406968 0.83 LMNA (0.53) LMNAALDH1A1NPC1RAB9ANPSR1
SCHEMBL17110205 0.83 LRRK2 (0.34) ALDH1A1KDM4E
SCHEMBL17110181 0.82 LMNA (0.42) LMNAALDH1A1NPC1RAB9ANPSR1
SCHEMBL1407122 0.82 LMNA (0.44) LMNAALDH1A1NPC1RAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266824-A1 Pyrazole Amide Derivative RORC, RORB, RORA LMNA 4719/4885ALDH1A1 923/4885NPC1 1718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.